Katja Pokrovskaja Tamm

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Molekylärbiolog, Med. Dr. i Tumörbiologi och docent på KI. Anställt som
teamledare och koordinator på OnkPat. Uppdrag som miljö-och
hållbarhetsombud på OnkPat. Ingår i miljörådet på KI
2011 Docent på KI
1999 Med. Dr., Institution för Mikrobiologi tumör- och cellbiologi,
Karolinska institutet.
1983 MSc. i Molekylär genetik, Lomonosov Moskva universitet, Ryska
Federationen

Forskningsbeskrivning

I mina projekt fokuserar vi på att analysera molekylärt landskap i
tumörceller bl.a. vid Akut lymfatisk leukemi (ALL) hos barn för att hitta
nya redskap för att förfina diagnos och möjlighet att skapa en mer
”skräddarsydd” behandling för specifika patientgrupper
/Mer information finns på den engelska sidan/

Undervisning

/Information finns på den Engelska sidan/

Artiklar

Article: LEUKEMIA. 2023;37(3):550-559

Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children.

Stratmann S; Vesterlund M; Umer HM; Eshtad S; Skaftason A; Herlin MK; Sundström C; Eriksson A; Höglund M; Palle J; Abrahamsson J; Jahnukainen K; Munthe-Kaas MC; Zeller B; Tamm KP; Lindskog C; Cavelier L; Lehtiö J; Holmfeldt L
Article: HEMASPHERE. 2022;6(10):e785

Duplex Sequencing Uncovers Recurrent Low-frequency Cancer-associated Mutations in Infant and Childhood KMT2A-rearranged Acute Leukemia.

Pilheden M; Ahlgren L; Hyrenius-Wittsten A; Gonzalez-Pena V; Sturesson H; Hansen Marquart HV; Lausen B; Castor A; Pronk CJ; Barbany G; Pokrovskaja Tamm K; Fogelstrand L; Lohi O; Norén-Nyström U; Asklin J; Chen Y; Song G; Walsh M; Ma J; Zhang J; Saal LH; Gawad C; Hagström-Andersson AK
Article: NATURE COMMUNICATIONS. 2022;13(1):1691

Integrative multi-omics and drug response profiling of childhood acute lymphoblastic leukemia cell lines.

Leo IR; Aswad L; Stahl M; Kunold E; Post F; Erkers T; Struyf N; Mermelekas G; Joshi RN; Gracia-Villacampa E; Östling P; Kallioniemi OP; Tamm KP; Siavelis I; Lehtiö J; Vesterlund M; Jafari R
Article: BLOOD ADVANCES. 2022;6(1):152-164

Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression.

Stratmann S; Yones SA; Garbulowski M; Sun J; Skaftason A; Mayrhofer M; Norgren N; Herlin MK; Sundström C; Eriksson A; Höglund M; Palle J; Abrahamsson J; Jahnukainen K; Munthe-Kaas MC; Zeller B; Tamm KP; Cavelier L; Komorowski J; Holmfeldt L
Article: SCIENTIFIC REPORTS. 2021;11(1):15988

Mutational patterns and clonal evolution from diagnosis to relapse in pediatric acute lymphoblastic leukemia.

Sayyab S; Lundmark A; Larsson M; Ringnér M; Nystedt S; Marincevic-Zuniga Y; Tamm KP; Abrahamsson J; Fogelstrand L; Heyman M; Norén-Nyström U; Lönnerholm G; Harila-Saari A; Berglund EC; Nordlund J; Syvänen A-C
Article: SCIENTIFIC REPORTS. 2021;11(1):11023

PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma.

Vidarsdottir L; Azimi A; Das I; Sigvaldadottir I; Suryo Rahmanto A; Petri A; Kauppinen S; Ingvar C; Jönsson G; Olsson H; Frostvik Stolt M; Tuominen R; Sangfelt O; Pokrovskaja Tamm K; Hansson J; Grandér D; Egyházi Brage S; Johnsson P
Article: BLOOD ADVANCES. 2021;5(3):900-912

Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets.

Stratmann S; Yones SA; Mayrhofer M; Norgren N; Skaftason A; Sun J; Smolinska K; Komorowski J; Herlin MK; Sundström C; Eriksson A; Höglund M; Palle J; Abrahamsson J; Jahnukainen K; Munthe-Kaas MC; Zeller B; Tamm KP; Cavelier L; Holmfeldt L
Article: MELANOMA RESEARCH. 2020;30(5):443-454

Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenib.

Vidarsdottir L; Fernandes RV; Zachariadis V; Das I; Edsbäcker E; Sigvaldadottir I; Azimi A; Höiom V; Hansson J; Grandér D; Egyházi Brage S; Pokrovskaja Tamm K
Article: SCIENCE ADVANCES. 2020;6(12):eaax7945

Irreversible TrxR1 inhibitors block STAT3 activity and induce cancer cell death.

Busker S; Qian W; Haraldsson M; Espinosa B; Johansson L; Attarha S; Kolosenko I; Liu J; Dagnell M; Grandér D; Arnér ESJ; Tamm KP; Page BDG
Article: EMBO MOLECULAR MEDICINE. 2020;12(3):e10419

Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy.

Rudd SG; Tsesmetzis N; Sanjiv K; Paulin CB; Sandhow L; Kutzner J; Hed Myrberg I; Bunten SS; Axelsson H; Zhang SM; Rasti A; Mäkelä P; Coggins SA; Tao S; Suman S; Branca RM; Mermelekas G; Wiita E; Lee S; Walfridsson J; Schinazi RF; Kim B; Lehtiö J; Rassidakis GZ; Pokrovskaja Tamm K; Warpman-Berglund U; Heyman M; Grandér D; Lehmann S; Lundbäck T; Qian H; Henter J-I; Schaller T; Helleday T; Herold N
Article: SCIENTIFIC REPORTS. 2019;9(1):536

STAT3 is activated in multicellular spheroids of colon carcinoma cells and mediates expression of IRF9 and interferon stimulated genes.

Edsbäcker E; Serviss JT; Kolosenko I; Palm-Apergi C; De Milito A; Tamm KP
Article: CANCER LETTERS. 2018;435:32-43

Targeting autophagy by small molecule inhibitors of vacuolar protein sorting 34 (Vps34) improves the sensitivity of breast cancer cells to Sunitinib.

Dyczynski M; Yu Y; Otrocka M; Parpal S; Braga T; Henley AB; Zazzi H; Lerner M; Wennerberg K; Viklund J; Martinsson J; Grandér D; De Milito A; Pokrovskaja Tamm K
Article: CELL DEATH & DISEASE. 2018;9(9):846

Metabolic reprogramming of acute lymphoblastic leukemia cells in response to glucocorticoid treatment.

Dyczynski M; Vesterlund M; Björklund A-C; Zachariadis V; Janssen J; Gallart-Ayala H; Daskalaki E; Wheelock CE; Lehtiö J; Grandér D; Tamm KP; Nilsson R
Article: CELL DEATH & DISEASE. 2018;9(7):736

An antisense RNA capable of modulating the expression of the tumor suppressor microRNA-34a.

Serviss JT; Andrews N; Van den Eynden J; Richter FC; Houtman M; Vesterlund M; Schwarzmueller L; Johnsson P; Larsson E; Grandér D; Pokrovskaja Tamm K
Article: EJNMMI RESEARCH. 2018;8(1):27

Hallmarks in prostate cancer imaging with Ga68-PSMA-11-PET/CT with reference to detection limits and quantitative properties.

Sanchez-Crespo A; Jussing E; Björklund A-C; Pokrovskaja Tamm K
Article: NATURE MEDICINE. 2017;23(2):256-263

Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies.

Herold N; Rudd SG; Ljungblad L; Sanjiv K; Myrberg IH; Paulin CBJ; Heshmati Y; Hagenkort A; Kutzner J; Page BDG; Calderón-Montaño JM; Loseva O; Jemth A-S; Bulli L; Axelsson H; Tesi B; Valerie NCK; Höglund A; Bladh J; Wiita E; Sundin M; Uhlin M; Rassidakis G; Heyman M; Tamm KP; Warpman-Berglund U; Walfridsson J; Lehmann S; Grandér D; Lundbäck T; Kogner P; Henter J-I; Helleday T; Schaller T
Article: PLOS ONE. 2017;12(6):e0178844

Identification of novel small molecules that inhibit STAT3-dependent transcription and function.

Kolosenko I; Yu Y; Busker S; Dyczynski M; Liu J; Haraldsson M; Palm Apergi C; Helleday T; Tamm KP; Page BDG; Grander D
Article: INTERNATIONAL JOURNAL OF CANCER. 2015;136(4):E51-E61

Cell crowding induces interferon regulatory factor 9, which confers resistance to chemotherapeutic drugs.

Kolosenko I; Fryknäs M; Forsberg S; Johnsson P; Cheon H; Holvey-Bates EG; Edsbäcker E; Pellegrini P; Rassoolzadeh H; Brnjic S; Larsson R; Stark GR; Grandér D; Linder S; Tamm KP; De Milito A
Article: CURRENT MEDICINAL CHEMISTRY. 2014;21(26):3042-3047

IL-6 activated JAK/STAT3 pathway and sensitivity to Hsp90 inhibitors in multiple myeloma.

Kolosenko I; Grander D; Tamm KP
Article: LEUKEMIA & LYMPHOMA. 2013;54(5):996-1003

Patients with activated B-cell like diffuse large B-cell lymphoma in high and low infectious disease areas have different inflammatory gene signatures.

Högfeldt T; Bahnassy AA; Kwiecinska A; Osterborg A; Tamm KP; Porwit A; Zekri A-RN; Lundahl J; Khaled HM; Mellstedt H; Moshfegh A
Article: LEUKEMIA & LYMPHOMA. 2013;54(4):843-850

Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies.

Daneshmanesh AH; Porwit A; Hojjat-Farsangi M; Jeddi-Tehrani M; Tamm KP; Grandér D; Lehmann S; Norin S; Shokri F; Rabbani H; Mellstedt H; Österborg A
Article: EXPERIMENTAL CELL RESEARCH. 2013;319(5):600-611

An activated JAK/STAT3 pathway and CD45 expression are associated with sensitivity to Hsp90 inhibitors in multiple myeloma.

Lin H; Kolosenko I; Björklund A-C; Protsyuk D; Österborg A; Grandér D; Tamm KP
Article: MOLECULAR PHARMACOLOGY. 2013;83(1):245-255

Requirement of apoptotic protease-activating factor-1 for bortezomib-induced apoptosis but not for Fas-mediated apoptosis in human leukemic cells.

Ottosson-Wadlund A; Ceder R; Preta G; Pokrovskaja K; Grafström RC; Heyman M; Söderhäll S; Grandér D; Hedenfalk I; Robertson JD; Fadeel B
Article: NATURE COMMUNICATIONS. 2012;3:976

Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway.

Arabi A; Ullah K; Branca RMM; Johansson J; Bandarra D; Haneklaus M; Fu J; Ariës I; Nilsson P; Den Boer ML; Pokrovskaja K; Grandér D; Xiao G; Rocha S; Lehtiö J; Sangfelt O
Article: BLOOD CANCER JOURNAL. 2011;1(7):e31

Glucocorticoid-induced cell death is mediated through reduced glucose metabolism in lymphoid leukemia cells.

Buentke E; Nordström A; Lin H; Björklund A-C; Laane E; Harada M; Lu L; Tegnebratt T; Stone-Elander S; Heyman M; Söderhäll S; Porwit A; Ostenson C-G; Shoshan M; Tamm KP; Grandér D
Article: EXPERIMENTAL CELL RESEARCH. 2011;317(1):9-19

Activation of STAT1 is required for interferon-alpha-mediated cell death.

Arulampalam V; Kolosenko I; Hjortsberg L; Björklund A-C; Grandér D; Tamm KP
Article: AUTOPHAGY. 2009;5(8):1198-1200

Autophagy as the main means of cytotoxicity by glucocorticoids in hematological malignancies.

Grandér D; Kharaziha P; Laane E; Pokrovskaja K; Panaretakis T
Article: CELL DEATH AND DIFFERENTIATION. 2009;16(7):1018-1029

Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy.

Laane E; Tamm KP; Buentke E; Ito K; Kharaziha P; Oscarsson J; Corcoran M; Björklund A-C; Hultenby K; Lundin J; Heyman M; Söderhäll S; Mazur J; Porwit A; Pandolfi PP; Zhivotovsky B; Panaretakis T; Grandér D
Article: GUT. 2009;58(4):560-569

Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes.

Ahlén G; Derk E; Weiland M; Jiao J; Rahbin N; Aleman S; Peterson DL; Pokrovskaja K; Grandér D; Frelin L; Sällberg M
Article: MOLECULAR BIOLOGY OF THE CELL. 2008;19(1):41-50

Interferon alpha induces nucleus-independent apoptosis by activating extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase downstream of phosphatidylinositol 3-kinase and mammalian target of rapamycin.

Panaretakis T; Hjortsberg L; Tamm KP; Björklund A-C; Joseph B; Grandér D
Article: EXPERIMENTAL CELL RESEARCH. 2007;313(19):4015-4024

Interferon alpha induces cell death through interference with interleukin 6 signaling and inhibition of STAT3 activity.

Thyrell L; Arulampalam V; Hjortsberg L; Farnebo M; Grandér D; Pokrovskaja Tamm K
Article: HAEMATOLOGICA. 2007;92(11):1460-1469

Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members.

Laane E; Panaretakis T; Pokrovskaja K; Buentke E; Corcoran M; Söderhäll S; Heyman M; Mazur J; Zhivotovsky B; Porwit A; Grandér D
Article: EXPERIMENTAL CELL RESEARCH. 2007;313(2):404-414

Phosphoinositide 3-kinase regulates a subset of interferon-alpha-stimulated genes.

Hjortsberg L; Lindvall C; Corcoran M; Arulampalam V; Chan D; Thyrell L; Nordenskjold M; Grandér D; Pokrovskaja K
Article: MOLECULAR BIOLOGY OF THE CELL. 2005;16(8):3821-3831

Doxorubicin requires the sequential activation of caspase-2, protein kinase Cdelta, and c-Jun NH2-terminal kinase to induce apoptosis.

Panaretakis T; Laane E; Pokrovskaja K; Björklund A-C; Moustakas A; Zhivotovsky B; Heyman M; Shoshan MC; Grandér D
Article: JOURNAL OF INTERFERON AND CYTOKINE RESEARCH. 2005;25(2):63-72

The HPV-16 E7 oncogene sensitizes malignant cells to IFN-alpha-induced apoptosis.

Thyrell L; Sangfelt O; Zhivotovsky B; Pokrovskaja K; Wang Y; Einhorn S; Grandér D
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2004;279(23):24152-24162

Interferon alpha-induced apoptosis in tumor cells is mediated through the phosphoinositide 3-kinase/mammalian target of rapamycin signaling pathway.

Thyrell L; Hjortsberg L; Arulampalam V; Panaretakis T; Uhles S; Dagnell M; Zhivotovsky B; Leibiger I; Grandér D; Pokrovskaja K
Article: ONCOGENE. 2003;22(29):4543-4556

Interferon-alpha-induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and Bax.

Panaretakis T; Pokrovskaja K; Shoshan MC; Grandér D
Article: INTERNATIONAL JOURNAL OF CANCER. 2003;105(5):644-653

EBV-encoded EBNA-5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF-expressing cells.

Kashuba E; Mattsson K; Pokrovskaja K; Kiss C; Protopopova M; Ehlin-Henriksson B; Klein G; Szekely L
Article: IMMUNOLOGY LETTERS. 2003;88(1):1-13

DNA immunization efficiently targets conserved functional domains of protease and ATPase/helicase of nonstructural 3 protein (NS3) of human hepatitis C virus.

Isaguliants MG; Petrakova NV; Mokhonov VV; Pokrovskaya K; Suzdaltzeva YG; Krivonos AV; Zaberezhny AD; Garaev MM; Smirnov VD; Nordenfelt E
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2002;277(46):44317-44326

Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin.

Panaretakis T; Pokrovskaja K; Shoshan MC; Grandér D
Article: INTERNATIONAL JOURNAL OF CANCER. 2002;99(5):705-712

CD40 ligation downregulates EBNA-2 and LMP-1 expression in EBV-transformed lymphoblastoid cell lines.

Pokrovskaja K; Ehlin-Henriksson B; Kiss C; Challa A; Gordon J; Gogolak P; Klein G; Szekely L
Article: ONCOGENE. 2002;21(8):1251-1262

Mechanisms of Interferon-alpha induced apoptosis in malignant cells.

Thyrell L; Erickson S; Zhivotovsky B; Pokrovskaja K; Sangfelt O; Castro J; Einhorn S; Grandér D
Article: JOURNAL OF HUMAN VIROLOGY. 2001;4(5):227-237

Epstein-barr virus can infect B-chronic lymphocytic leukemia cells but it does not orchestrate the cell cycle regulatory proteins.

Maeda A; Bandobashi K; Nagy N; Teramoto N; Gogolák P; Pokrovskaja K; Székely L; Björkholm M; Klein G; Klein E
Article: JOURNAL OF GENERAL VIROLOGY. 2001;82(Pt 2):345-358

Proteasome inhibitor induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5.

Pokrovskaja K; Mattsson K; Kashuba E; Klein G; Szekely L
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2001;98(3):1012-1017

Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation.

Mattsson K; Pokrovskaja K; Kiss C; Klein G; Szekely L
Article: ONCOGENE. 2000;19(14):1801-1806

Epstein-Barr virus encoded nuclear protein EBNA-3 binds XAP-2, a protein associated with Hepatitis B virus X antigen.

Kashuba E; Kashuba V; Pokrovskaja K; Klein G; Szekely L
Article: INTERVIROLOGY. 2000;43(4-6):288-293

DNA-encoding enzymatically active HIV-1 reverse transcriptase, but not the inactive mutant, confers resistance to experimental HIV-1 challenge.

Isaguliants MG; Petrakova NN; Zuber B; Pokrovskaya K; Gizatullin R; Kostyuk DA; Kjerrström A; Winberg G; Kochetkov SN; Hinkula J; Wahren B
Article: JOURNAL OF GENERAL VIROLOGY. 1999;80 ( Pt 11):2889-2900

Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin- associated nuclear bodies.

Szekely L; Kiss C; Mattsson K; Kashuba E; Pokrovskaja K; Juhasz A; Holmvall P; Klein G
Article: INTERNATIONAL JOURNAL OF CANCER. 1999;81(4):543-550

Expression of cyclin D2 and D3 in lymphoid lesions.

Teramoto N; Pokrovskaja K; Szekely L; Polack A; Yoshino T; Akagi T; Klein G
Article: JOURNAL OF GENERAL VIROLOGY. 1999;80 ( Pt 4):987-995

Epstein-Barr virus infection and mitogen stimulation of normal B cells induces wild-type p53 without subsequent growth arrest or apoptosis.

Pokrovskaja K; Okan I; Kashuba E; L Wbeer M; Klein G; Szekely L
Article: FEBS LETTERS. 1999;447(2-3):232-236

Eukaryotic expression of enzymatically active human immunodeficiency virus type 1 reverse transcriptase.

Isaguliants MG; Pokrovskaya K; Kashuba VI; Pokholok D; Hinkula J; Wahren B; Kochetkov SN
Article: JOURNAL OF HUMAN VIROLOGY. 1999;2(1):33-37

Epstein-Barr virus-encoded nuclear protein EBNA-3 interacts with the epsilon-subunit of the T-complex protein 1 chaperonin complex.

Kashuba E; Pokrovskaja K; Klein G; Szekely L
Article: JOURNAL OF VIROLOGICAL METHODS. 1998;73(1):89-97

Simultaneous detection of two independent antigens by double staining with two mouse monoclonal antibodies.

Teramoto N; Szekely L; Pokrovskaja K; Hu LF; Yoshino T; Akagi T; Klein G
Article: JOURNAL OF GENERAL VIROLOGY. 1998;79 ( Pt 6):1445-1452

Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line.

Szekely L; Chen F; Teramoto N; Ehlin-Henriksson B; Pokrovskaja K; Szeles A; Manneborg-Sandlund A; Löwbeer M; Lennette ET; Klein G
Article: JOURNAL OF GENERAL VIROLOGY. 1997;78 ( Pt 8):2031-2040

Epstein-Barr virus-encoded LMP-1 protein upregulates the pNDCF group of nucleoskeleton-cytoskeleton-associated proteins.

Pokrovskaja K; Trivedi P; Klein G; Szekely L
Article: MOLECULAR CANCER RESEARCH. 1997;8(5):599-609

Differential expression of nucleoskeleton- and cytoskeleton-associated proteins in Burkitt lymphoma-derived and Epstein-Barr virus-immortalized lymphoblastoid cell lines.

Szekely L; Pokrovskaja K; Klein G
Article: JOURNAL OF GENERAL VIROLOGY. 1997;78 ( Pt 4):893-903

Role of p53 mutation in polyomavirus-induced tumorigenesis.

Qian W; Kashuba E; Magnusson KP; Pokrovskaja K; Okan I; Klein G; Wiman KG
Article: MOLECULAR CANCER RESEARCH. 1996;7(12):1723-1732

Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.

Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
Article: ONCOGENE. 1996;12(12):2731-2735

Abrogation of p53-induced G1 arrest by the HPV 16 E7 protein does not inhibit p53-induced apoptosis.

Wang Y; Okan I; Pokrovskaja K; Wiman KG
Article: BLOOD. 1996;87(8):3360-3367

Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage.

Scuderi R; Palucka KA; Pokrovskaja K; Björkholm M; Wiman KG; Pisa P
Article: JOURNAL OF VIROLOGY. 1996;70(4):2562-2568

The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies.

Szekely L; Pokrovskaja K; Jiang WQ; de The H; Ringertz N; Klein G
Article: JOURNAL OF GENERAL VIROLOGY. 1995;76 ( Pt 10):2423-2432

Reversible nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 and hsp70 proteins after exposure to heat shock or cell density congestion.

Szekely L; Jiang WQ; Pokrovskaja K; Wiman KG; Klein G; Ringertz N
Visa fler

Alla övriga publikationer

Review: JOURNAL OF INTERFERON AND CYTOKINE RESEARCH. 2005;25(12):799-810

Alternative signaling pathways regulating type I interferon-induced apoptosis.

Pokrovskaja K; Panaretakis T; Grandér D
Other: ONCOGENE. 1995;10(9):1869-1874

Resting B-cells, EBV-infected B-blasts and established lymphoblastoid cell lines differ in their Rb, p53 and EBNA-5 expression patterns.

Szekely L; Pokrovskaja K; Jiang WQ; Selivanova G; Löwbeer M; Ringertz N; Wiman KG; Klein G

Om mig

Forskningsbeskrivning

Undervisning

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI